{{Rsnum
|rsid=12290811
|Gene=ODZ4
|Chromosome=11
|position=79372576
|Orientation=plus
|GMAF=0.1414
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=TENM4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 2.7 | 19.5 | 77.9
| HCB | 0.7 | 15.4 | 83.8
| JPT | 0.0 | 4.4 | 95.6
| YRI | 6.1 | 34.7 | 59.2
| ASW | 8.9 | 32.1 | 58.9
| CHB | 0.7 | 15.4 | 83.8
| CHD | 0.0 | 13.0 | 87.0
| GIH | 0.0 | 6.9 | 93.1
| LWK | 9.1 | 38.2 | 52.7
| MEX | 0.0 | 19.0 | 81.0
| MKK | 2.6 | 16.7 | 80.8
| TSI | 0.0 | 23.5 | 76.5
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs12290811
|PubMedID=18711365
|Condition=Bipolar disorder
|Gene=NR
|Risk Allele=A
|pValue=4.00E-006
|OR=1.2
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs12290811
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18711365; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS Results: Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder (Initial Sample Size: 1,098 cases, 1,267 controls; Replication Sample Size: 4,387 cases, 6,209 controls; Risk Allele: rs12290811-A). This variant is associated with Bipolar disorder.
|Drugs=
|Drug Classes=
|Diseases=Bipolar Disorder
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356413
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs12290811
|overall_frequency_n=17
|overall_frequency_d=126
|overall_frequency=0.134921
|n_genomes=14
|n_genomes_annotated=0
|n_haplomes=17
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{PMID Auto
|PMID=25124521
|Title=Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}